Oncopeptides AB (ONCO) Revenue

9 Followers

Statistics Market Cap Revenue

Oncopeptides AB Revenue

Oncopeptides AB had a revenue of 19.18M in the quarter ending Jun 30, 2025, with 44.59%. This bring the company's revenue in the last twelve months to 50.87M, Decreased 27.68%. In the fiscal year ending Dec 31, 2025, Oncopeptides AB had annual revenue of 71.12M with 124.72% growth.

Revenue (ttm)

50.87M

Revenue Growth

109.22%

P/S Ratio

9.93

Revenue/Employee

kr888,975

Employees

Market Cap

kr705.89M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	71.12M	39.47M	+124.72%
Dec 31, 2024	31.65M	-3.57M	-10.14%
Dec 31, 2023	35.22M	26.86M	+321.54%
Dec 31, 2022	8.36M	-109.94M	-92.94%
Dec 31, 2021	118.30M	―	+∞%
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―